Resolution to consolidate into a consolidated subsidiary to expand sales. Togo Medikit acquires all shares of T.G. Medical and its stock acquisition rights, becoming a wholly owned subsidiary. Shares acquired: 2,211 shares and 331 stock acquisition rights, ownership ratio: 100.0%. Impact on FY2027 is expected to be minor.<\/p>\n","protected":false},"comment_status":"open","ping_status":"closed","template":"","meta":{"Ticker":"","DATE":"","longName":"","company_name_ja":"","fullTimeEmployees":0,"address":"","phone":"","website":"","industry":"","sector":"","regularMarketPrice":0,"financialCurrency":"","marketCap":0,"fiftyTwoWeekLow":0,"fiftyTwoWeekHigh":0,"epsTrailingTwelveMonths":0,"epsForward":0,"bookValue":0,"totalRevenue":0,"OperatingIncome":0,"operatingMargins":0,"NetIncome":0,"profitMargins":0,"ebitda":0,"trailingPE":0,"forwardPE":0,"priceToBook":0,"returnOnEquity":0,"recommendationMean":0,"recommendationKey":"","targetMeanPrice":0,"numberOfAnalystOpinions":0,"analyst_earnings_data":"","dividendRate":0,"dividendYield":0,"payoutRatio":0,"totalEsg":0,"environmentScore":0,"socialScore":0,"governanceScore":0,"title":"","providerPublishTime":"","link":"","longBusinessSummary":"","longBusinessSummary_ja":"","quarterly_revenue":0,"quarterly_net_income":0,"quarterly_operating_profit":0,"enterprise_value":0,"company_officer_1_name":"","company_officer_1_title":"","company_officer_2_name":"","company_officer_2_title":"","company_officer_3_name":"","company_officer_3_title":"","company_officer_4_name":"","company_officer_4_title":"","company_officer_5_name":"","company_officer_5_title":"","company_officers_update_time":"","get_dividend_history_year1":0,"get_dividend_history_year2":0,"get_dividend_history_year3":0,"get_dividend_history_year4":0,"get_dividend_history_year5":0,"get_dividend_history_year6":0,"get_dividend_history_year7":0,"get_dividend_history_year8":0,"get_dividend_history_year9":0,"get_dividend_history_year10":0,"site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"jir_stock_code":"7749","jir_company_name":"Medikit Corporation","jir_importance":"\u2605\u2605\u2605\u2605\u2606","jir_publication_date":"2026-07-03","jir_source_link":"https:\/\/japanir.jp\/wp-content\/uploads\/2026\/07\/7749-20260703-01.pdf","jir_short_summary":"Resolution to consolidate into a consolidated subsidiary to expand sales. Togo Medikit acquires all shares of T.G. Medical and its stock acquisition rights, becoming a wholly owned subsidiary. Shares acquired: 2,211 shares and 331 stock acquisition rights, ownership ratio: 100.0%. Impact on FY2027 is expected to be minor.","jir_summary":"### Overview\nThis case involves Medikit Corporation approving at its board of directors to acquire all issued shares and stock acquisition rights to promote 100% subsidiary formation of T.G. Medical, thereby making it a subsidiary. The acquired shares are 2,211 shares and 331 stock acquisition rights, with a voting rights ownership of 100.0%. The contract signing date and the share transfer date are both July 3, 2026.\n\n### Impact and strategy going forward\nIn line with the NEXT 300 Neo medium-term plan, the company will strengthen the development of high-end medical device technology in the field of neurovascular treatment. T.G. Medical's current earnings are not disclosed, but through expanding domestic and international business and developing products that meet medical institutions' needs, it aims for long-term growth. The impact on consolidated results for the FY ending March 2027 is expected to be minor.","jir_financial_highlights":"Number of acquired shares: Shares 2,211 and Stock Acquisition Rights 331 (Unknown)\nShareholding before\/after acquisition: Before: 0 shares (After: 2,211 shares and 331 stock acquisition rights (Voting rights ownership: 100.0%))\nAcquisition value: Unknown (Unknown)\nTiming of subsidiary formation: Contract signing date \/ share transfer date: July 3, 2026 (Unknown)","jir_category":"","jir_hashtags":"#Medikit, #M&A, #JapanEquity","jir_key_figures":"Number of acquired shares: Shares 2,211 and Stock Acquisition Rights 331\nVoting rights ownership: 100.0%\nContract signing date \/ share transfer date: July 3, 2026","jir_meta_title":"[Medikit] Decision to Subsidiarize T.G. Medical Through Share Acquisition | July 2026","jir_meta_description":"Medikit acquires T.G. Medical's shares and stock acquisition rights to subsidiary it. Acquired shares: 2,211 and 331 stock acquisition rights, voting rights 100%, dated July 3, 2026. Details on growth strategy and impact.","jir_og_title":"[Medikit] Decision to Subsidiarize T.G. Medical | July 2026","jir_og_description":"Medikit acquires shares of T.G. Medical to subsidiary it. Shares 2,211 and stock acquisition rights 331, voting rights 100%. Dated July 3, 2026.","jir_og_image_url":"\/assets\/og\/company-general_ir.jpg","jir_chart_data_collection":"[]","ir_related_company":17478,"ir_release_date":"","ir_type":"","ir_is_new":false,"ir_document_url":"","jir_ir_type":"m_and_a_alliance","footnotes":""},"sector":[],"importance":[],"class_list":["post-75761","ir_release","type-ir_release","status-publish","hentry"],"yoast_head":"\n